HealthEquity (HQY) Stock Forecast, Price Target & Predictions
HQY Stock Forecast
HealthEquity stock forecast is as follows: an average price target of $107.50 (represents a 12.35% upside from HQY’s last price of $95.68) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
HQY Price Target
The average price target for HealthEquity (HQY) is $107.50 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $112.00 to $103.00. This represents a potential 12.35% upside from HQY's last price of $95.68.
HQY Analyst Ratings
According to 11 Wall Street analysts, HealthEquity's rating consensus is 'Buy'. The analyst rating breakdown for HQY stock is 0 'Strong Buy' (0.00%), 10 'Buy' (90.91%), 1 'Hold' (9.09%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
HealthEquity Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | Alexander Paris | Barrington | $112.00 | $95.39 | 17.41% | 17.06% |
| Sep 04, 2024 | George Hill | Deutsche Bank | $103.00 | $82.66 | 24.61% | 7.65% |
| Jun 20, 2024 | Stan Berenshteyn | Wells Fargo | $110.00 | $84.74 | 29.81% | 14.97% |
| Jun 04, 2024 | Scott Schoenhaus | KeyBanc | $100.00 | $83.40 | 19.90% | 4.52% |
| Jun 04, 2024 | Mark Marcon | Robert W. Baird | $104.00 | $81.22 | 28.05% | 8.70% |
| Jun 03, 2024 | Alexander Paris | Barrington | $100.00 | $81.03 | 23.41% | 4.52% |
| May 07, 2024 | Stan Berenshteyn | Wells Fargo | $105.00 | $79.27 | 32.46% | 9.74% |
| Apr 04, 2024 | Constantine Davides | JMP Securities | $101.00 | $79.90 | 26.41% | 5.56% |
| Mar 28, 2024 | Glen Santangelo | Jefferies | $95.00 | $79.72 | 19.17% | -0.71% |
| Mar 20, 2024 | Stephanie Davis | Barclays | $104.00 | $81.36 | 27.83% | 8.70% |
| Mar 20, 2024 | Sean Dodge | RBC Capital | $92.00 | $81.36 | 13.08% | -3.85% |
| Sep 21, 2023 | Mark Marcon | Robert W. Baird | $87.00 | $70.97 | 22.59% | -9.07% |
| Jun 06, 2023 | Scott Schoenhaus | Loop Capital Markets | $85.00 | $65.67 | 29.44% | -11.16% |
| Dec 12, 2022 | Raymond James | $85.00 | $62.52 | 35.96% | -11.16% | |
| Dec 07, 2022 | Guggenheim | $94.00 | $66.91 | 40.49% | -1.76% | |
| Dec 07, 2022 | Wells Fargo | $101.00 | $66.99 | 50.77% | 5.56% | |
| Dec 05, 2022 | RBC Capital | $75.00 | $65.52 | 14.47% | -21.61% | |
| Dec 14, 2021 | Charles Peters | Raymond James | $70.00 | $40.24 | 73.96% | -26.84% |
| Jul 01, 2021 | Scott Schoenhaus | Stephens | $100.00 | $81.09 | 23.32% | 4.52% |
| Jun 08, 2021 | Steven Halper | Cantor Fitzgerald | $85.00 | $81.44 | 4.37% | -11.16% |
The latest HealthEquity stock forecast, released on Dec 10, 2024 by Alexander Paris from Barrington, set a price target of $112.00, which represents a 17.41% increase from the stock price at the time of the forecast ($95.39), and a 17.06% increase from HQY last price ($95.68).
HealthEquity Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 11 |
| Avg Price Target | $112.00 | $112.00 | $102.36 |
| Last Closing Price | $95.68 | $95.68 | $95.68 |
| Upside/Downside | 17.06% | 17.06% | 6.98% |
In the current month, the average price target of HealthEquity stock is $112.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 17.06% increase as opposed to HealthEquity's last price of $95.68. This month's average price target is down 0.00% compared to last quarter, and up 9.42% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 10, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Sep 20, 2024 | RBC Capital | Buy | Buy | Hold |
| Sep 19, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Sep 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Sep 04, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jun 04, 2024 | Wells Fargo | Buy | Buy | Hold |
| Jun 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Jun 04, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Jun 04, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Jun 04, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Jun 03, 2024 | Jefferies | Buy | Buy | Hold |
| Jun 03, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jun 03, 2024 | Raymond James | Outperform | Outperform | Hold |
| May 07, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Apr 04, 2024 | JMP Securities | Market Outperform | Outperform | Initialise |
| Apr 04, 2024 | JMP Securities | Market Outperform | Initialise | |
| Mar 28, 2024 | Jefferies | Buy | Buy | Hold |
| Sep 21, 2023 | Barclays | Outperform | Upgrade | |
| Jun 06, 2023 | KeyBanc | Overweight | Overweight | Hold |
| Dec 12, 2022 | Raymond James | Outperform | Outperform | Hold |
| Dec 07, 2022 | Guggenheim | Buy | Buy | Hold |
| Dec 07, 2022 | Wells Fargo | Overweight | Overweight | Hold |
| Dec 05, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Oct 21, 2022 | Goldman Sachs | Neutral | Upgrade | |
| Feb 24, 2022 | Deutsche Bank | Buy | Buy | Hold |
HealthEquity's last stock rating was published by JMP Securities on Dec 10, 2024. The company gave HQY a "Outperform" rating, the same as its previous rate.
HealthEquity Financial Forecast
HealthEquity Revenue Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $262.39M | $249.22M | $243.55M | - | $233.84M | $216.09M | $206.14M | - | $203.30M | $179.95M | $189.10M | - | $188.17M | $179.35M | $176.04M | - | $201.20M | $157.12M |
| Avg Forecast | $379.09M | $362.76M | $361.62M | $358.14M | $333.93M | $320.33M | $318.97M | $318.67M | $305.48M | $290.09M | $285.13M | $277.91M | $258.69M | $243.61M | $239.96M | $239.39M | $230.73M | $206.79M | $203.88M | $203.98M | $199.88M | $183.97M | $185.09M | $181.20M | $185.78M | $176.82M | $171.28M | $193.72M | $199.31M | $152.09M |
| High Forecast | $384.76M | $368.19M | $367.03M | $363.51M | $338.93M | $325.13M | $323.75M | $323.44M | $308.89M | $294.68M | $285.13M | $277.91M | $258.84M | $252.26M | $243.56M | $242.98M | $234.18M | $209.95M | $207.00M | $207.11M | $202.94M | $186.79M | $187.93M | $183.98M | $188.63M | $179.53M | $173.91M | $196.69M | $202.37M | $154.42M |
| Low Forecast | $373.22M | $357.15M | $356.02M | $352.60M | $328.77M | $315.38M | $314.04M | $313.74M | $301.57M | $283.77M | $285.13M | $277.91M | $258.55M | $239.68M | $236.25M | $235.69M | $227.16M | $203.87M | $201.01M | $201.11M | $197.07M | $181.39M | $182.49M | $178.65M | $183.17M | $174.33M | $168.88M | $191.00M | $196.51M | $149.95M |
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.01% | - | 1.01% | 1.04% | 1.01% | - | 1.02% | 0.98% | 1.02% | - | 1.01% | 1.01% | 1.03% | - | 1.01% | 1.03% |
HealthEquity's average Quarter revenue forecast for May 24 based on 6 analysts is $277.91M, with a low forecast of $277.91M, and a high forecast of $277.91M. HQY's average Quarter revenue forecast represents a 5.92% increase compared to the company's last Quarter revenue of $262.39M (Jan 24).
HealthEquity EBITDA Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $79.08M | $30.89M | $24.74M | - | $59.90M | $52.99M | $46.04M | - | $5.81M | $36.30M | $32.52M | - | $35.85M | $40.46M | $36.80M | - | $40.37M | $-1.96M |
| Avg Forecast | $80.41M | $76.95M | $76.71M | $75.97M | $70.83M | $67.95M | $67.66M | $67.60M | $64.80M | $61.53M | $60.48M | $7.67M | $54.87M | $51.67M | $50.90M | $6.97M | $39.93M | $53.94M | $53.18M | $6.33M | $52.14M | $47.99M | $48.28M | $34.06M | $48.46M | $46.12M | $44.68M | $35.76M | $51.99M | $39.67M |
| High Forecast | $81.62M | $78.10M | $77.86M | $77.11M | $71.89M | $68.97M | $68.67M | $68.61M | $65.52M | $62.51M | $60.48M | $9.20M | $54.91M | $53.51M | $51.66M | $8.36M | $47.92M | $54.77M | $54.00M | $7.60M | $52.94M | $48.73M | $49.02M | $40.87M | $49.21M | $46.83M | $45.37M | $42.91M | $52.79M | $40.28M |
| Low Forecast | $79.17M | $75.76M | $75.52M | $74.79M | $69.74M | $66.90M | $66.61M | $66.55M | $63.97M | $60.19M | $60.48M | $6.13M | $54.84M | $50.84M | $50.11M | $5.57M | $31.94M | $53.18M | $52.44M | $5.07M | $51.41M | $47.32M | $47.60M | $27.24M | $47.78M | $45.48M | $44.05M | $28.61M | $51.26M | $39.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.44% | 0.60% | 0.49% | - | 1.50% | 0.98% | 0.87% | - | 0.11% | 0.76% | 0.67% | - | 0.74% | 0.88% | 0.82% | - | 0.78% | -0.05% |
6 analysts predict HQY's average Quarter EBITDA for May 24 to be $7.67M, with a high of $9.20M and a low of $6.13M. This is -90.31% lower than HealthEquity's previous annual EBITDA (Jan 24) of $79.08M.
HealthEquity Net Income Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $26.36M | $14.67M | $10.58M | - | $-209.00K | $-1.64M | $-10.65M | - | $-32.82M | $-5.04M | $-3.82M | - | $5.37M | $1.79M | $-148.00K | - | $-190.00K | $-21.33M |
| Avg Forecast | - | - | - | - | $84.91M | $79.77M | $83.46M | $79.33M | $63.60M | $64.02M | $61.96M | $-43.32M | $50.33M | $44.31M | $42.28M | $-39.38M | $-5.54M | $30.72M | $29.27M | $-35.80M | $19.02M | $30.74M | $32.16M | $5.10M | $35.88M | $31.77M | $24.30M | $-168.28K | $31.13M | $19.26M |
| High Forecast | - | - | - | - | $86.56M | $81.32M | $85.09M | $80.87M | $68.83M | $67.63M | $61.96M | $-34.66M | $51.05M | $48.83M | $43.10M | $-31.51M | $-4.43M | $31.33M | $29.85M | $-28.64M | $19.40M | $31.35M | $32.80M | $6.12M | $36.59M | $32.40M | $24.78M | $-134.63K | $31.75M | $19.64M |
| Low Forecast | - | - | - | - | $83.20M | $78.17M | $81.79M | $77.73M | $59.24M | $62.22M | $61.96M | $-51.98M | $49.62M | $42.50M | $41.43M | $-47.26M | $-6.65M | $30.16M | $28.73M | $-42.96M | $18.67M | $30.18M | $31.57M | $4.08M | $35.22M | $31.19M | $23.85M | $-201.94K | $30.56M | $18.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.52% | 0.33% | 0.25% | - | 0.04% | -0.05% | -0.36% | - | -1.73% | -0.16% | -0.12% | - | 0.15% | 0.06% | -0.01% | - | -0.01% | -1.11% |
HealthEquity's average Quarter net income forecast for May 24 is $-43.32M, with a range of $-51.98M to $-34.66M. HQY's average Quarter net income forecast represents a -264.31% decrease compared to the company's last Quarter net income of $26.36M (Jan 24).
HealthEquity SG&A Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $43.70M | $46.03M | $46.21M | - | $40.03M | $42.38M | $41.78M | - | $37.19M | $32.73M | $38.29M | - | $36.37M | $34.98M | $32.66M | - | $37.30M | $31.88M |
| Avg Forecast | $71.47M | $68.39M | $68.17M | $67.52M | $62.95M | $60.39M | $60.13M | $60.08M | $57.59M | $54.69M | $53.75M | $49.09M | $48.77M | $45.92M | $45.24M | $44.63M | $36.00M | $38.98M | $38.43M | $40.57M | $37.68M | $34.68M | $34.89M | $34.55M | $35.02M | $33.33M | $32.29M | $33.04M | $37.57M | $28.67M |
| High Forecast | $72.54M | $69.41M | $69.19M | $68.53M | $63.90M | $61.29M | $61.03M | $60.98M | $58.23M | $55.55M | $53.75M | $58.91M | $48.80M | $47.56M | $45.92M | $53.56M | $43.20M | $39.58M | $39.02M | $48.69M | $38.26M | $35.21M | $35.43M | $41.46M | $35.56M | $33.84M | $32.79M | $39.65M | $38.15M | $29.11M |
| Low Forecast | $70.36M | $67.33M | $67.12M | $66.47M | $61.98M | $59.46M | $59.20M | $59.15M | $56.85M | $53.50M | $53.75M | $39.28M | $48.74M | $45.18M | $44.54M | $35.71M | $28.80M | $38.43M | $37.89M | $32.46M | $37.15M | $34.20M | $34.40M | $27.64M | $34.53M | $32.87M | $31.84M | $26.43M | $37.05M | $28.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 1.00% | 1.02% | - | 1.11% | 1.09% | 1.09% | - | 0.99% | 0.94% | 1.10% | - | 1.04% | 1.05% | 1.01% | - | 0.99% | 1.11% |
HealthEquity's average Quarter SG&A projection for May 24 is $49.09M, based on 6 Wall Street analysts, with a range of $39.28M to $58.91M. The forecast indicates a 12.35% rise compared to HQY last annual SG&A of $43.70M (Jan 24).
HealthEquity EPS Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.31 | $0.17 | $0.12 | - | $-0.00 | $-0.02 | $-0.13 | - | $-0.39 | $-0.06 | $-0.05 | - | $0.07 | $0.02 | $-0.00 | - | $-0.00 | $-0.30 |
| Avg Forecast | - | - | - | - | $0.96 | $0.90 | $0.94 | $0.90 | $0.72 | $0.72 | $0.70 | $0.66 | $0.57 | $0.50 | $0.48 | $0.41 | $0.35 | $0.35 | $0.33 | $0.26 | $0.21 | $0.35 | $0.36 | $0.32 | $0.40 | $0.36 | $0.27 | $0.44 | $0.35 | $0.22 |
| High Forecast | - | - | - | - | $0.98 | $0.92 | $0.96 | $0.91 | $0.78 | $0.76 | $0.70 | $0.66 | $0.58 | $0.55 | $0.49 | $0.41 | $0.36 | $0.35 | $0.34 | $0.27 | $0.22 | $0.35 | $0.37 | $0.33 | $0.41 | $0.37 | $0.28 | $0.44 | $0.36 | $0.22 |
| Low Forecast | - | - | - | - | $0.94 | $0.88 | $0.92 | $0.88 | $0.67 | $0.70 | $0.70 | $0.66 | $0.56 | $0.48 | $0.47 | $0.40 | $0.34 | $0.34 | $0.32 | $0.26 | $0.21 | $0.34 | $0.36 | $0.32 | $0.40 | $0.35 | $0.27 | $0.43 | $0.34 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.34% | 0.25% | - | -0.01% | -0.06% | -0.39% | - | -1.82% | -0.17% | -0.14% | - | 0.17% | 0.06% | -0.01% | - | -0.01% | -1.38% |
According to 6 Wall Street analysts, HealthEquity's projected average Quarter EPS for May 24 is $0.66, with a low estimate of $0.66 and a high estimate of $0.66. This represents a 111.73% increase compared to HQY previous annual EPS of $0.31 (Jan 24).